Gilead Sciences' top products based on revenue 2016-2019

This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2016 to 2019, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2018, Gilead Sciences' product Atripla generated some 1.2 billion U.S. dollars in revenue. The company shot to the public spotlight after trails of its drug Remdesivir against Corona started in 2020.

Top products of Gilead Sciences from 2016 to 2019s, based on revenue

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2016 to 2019

Special properties

Supplementary notes

Data for 2013-2015 were taken from previous annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotech industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.